Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
2061310 | GW284543 | 790186-68-4 | 98% Min. | |
GW284543, also known as UNC10225170;, is a potent and selective MEK5 inhibitor with t | ||||
206103 | G-1 | 881639-98-1 | 98% Min. | |
G-1 is a selective agonist for GPER. It acts by blocking tubulin polymerization. | ||||
203401 | Glumetinib | 1642581-63-2 | 98% Min. | |
Glumetinib, also known as SCC244, is a novel, potent and highly selective inhibitor o | ||||
111892 | GNE-2861 | 1394121-05-1 | 98% Min. | |
GNE-2861 is a potent and exquisitely kinase-selective Group II PAK inhibitor (PAK4 Ki | ||||
193293 | GSK-199 | 1549811-53-1 | >98% | |
GSK199 is a selective PAD4 inhibitor with half-maximum inhibitory concentration (IC50 | ||||
193221 | GS-626510 | 1637770-13-8 | >98% | |
GS-626510 is a potent BET family bromodomains inhibitor. It acts by targeting BRD2/3/ | ||||
193194 | GSK2837808A | 1445879-21-9 | >98% | |
GSK2837808A is a potent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 val | ||||
193185 | GSK-963 | 2049868-46-2 | >98% | |
GSK-963, also known as GSK'963 or GSK963, is a potent and selective inhibitor of | ||||
192284 | GNE-9605 | 1536200-31-3 | >98% | |
GNE-9605 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-ric | ||||
192281 | GSK3004774 | 2138814-32-9 | >98% | |
GSK3004774 is a potent, nonabsorbable agonist of CaSR, with an pEC50 of 7.3, 6.6 and | ||||
192251 | GW-3965 HCl | 405911-17-3 | >98% | |
GW-3965 is a liver X receptor agonist. GW3965 represses the production of pro-inflamm | ||||
192224 | GSK2334470 | 1227911-45-6 | >98% | |
GSK2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor ( | ||||
192201 | GSK269962 HCl | 2095432-71-4 | >98% | |
GSK269962 is a selective ROCK inhibitor with IC50 values of 1.6 and 6 nM for ROCK-I a | ||||
192194 | GW-803430 | 515141-51-2 | >98% | |
GW-803430 is a potent, orally active and selective melanin-concentrating hormone rece | ||||
192181 | GNE-477 | 1032754-81-6 | >98% | |
GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor. | ||||
191255 | GSKJ1 | 1373422-53-7 | >98% | |
GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has signi | ||||
191144 | GSK2643943A | // | >98% | |
GSK2643943A is a potent USP20 inhibitor with IC50 = 160 nM. | ||||
19185 | GSK-2807 | 2245255-65-4 | >98% | |
GSK-2807 is a potent and selective, SAM-competitive inhibitor of SMYD3. | ||||
1812291 | GNE-6640 | 2009273-67-8 | >98% | |
GNE-6640 is a novel selective USP7 inhibitor, inducing tumor cell death. GNE-6640 enh | ||||
1812102 | GSK1940029 | 1150701-66-8 | >98% | |
GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potent | ||||
181241 | GSK2814338 | 1420367-28-7 | >98% | |
GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor. | ||||
1811301 | GDC-0927 | 1642297-01-5 | >98% | |
GDC-0927, also known as SRN-927, is a next-generation oral SERD which appears to have | ||||
1811266 | GSK-5959 | 901245-65-6 | >98% | |
GSK-5959 is a potent and selective BRPF1 bromodomain inhibitor (IC50 = 80 nM). | ||||
1811263 | GW-870086 | 827319-43-7 | >98% | |
GW-870086 is a glucocorticoid receptor agonist potentially for the treatment of asthm | ||||
1811233 | GSK9311 | 1923851-49-3 | >98% | |
GSK9311 is a potent and highly selective inhibitor of the BRPF bromodomain (BRPDF1 pI | ||||
1811231 | GW1100 | 306974-70-9 | >98% | |
GW1100 is a a selective antagonist of GPR40. | ||||
181151 | GW6471 | 880635-03-0 | >98% | |
GW6471 is a PPAR α antagonist (IC50 = 0.24 μ M). GW6471 enhances the binding affini | ||||
1810292 | GSK-2830371 | 1404456-53-6 | >98% | |
GSK 2830371 is a WiP1 inhibitor. It inhibits cell growth and tumor growth in lymphoma | ||||
1810176 | GENZ-882706 | 2070864-35-4 | >98% | |
GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) Inhibitor. | ||||
189272 | GDC-0575 | 1196541-47-5 | >98% | |
GDC-0575 (ARRY-575, RG7741) is a potent and selective CHK1 inhibitor with an IC50 of |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1